A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to count, over a 10-year period, the number of occurrences of Fibrosing Colonopathy in US patients with CF who are being treated with specific Pancreatic Enzyme Replacement Therapy (PERT), those enzymes being CREON?, PANCREAZE?, ZENPEP?, or ULTRESA?.
Description
The purpose of this study is to count, over a 10-year period, the number of occurrences of Fibrosing Colonopathy in US patients with CF who are being treated with specific Pancreatic Enzyme Replacement Therapy (PERT), those enzymes being CREON?, PANCREAZE?, ZENPEP?, or ULTRESA?.
Details
| Condition | cystic fibrosis |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX6535 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.